Head-to-Head Comparisons of Serum Prolactin Elevation Induced by 9 Second-Generation Antipsychotics in a Large Cohort of Patients with Schizophrenia: Analysis from a Real-World Study Database
Lei Zhang,Jingjing Huang,Wenjuan Yu,Shen He,Yimin Yu,Fei Gu,Dan Tang,Hao Wang,Qingshan Zheng,YIfeng Shen,Jianping Zhang,Huafang Li
DOI: https://doi.org/10.2139/ssrn.3988000
2021-01-01
SSRN Electronic Journal
Abstract:Background: Antipsychotic-induced hyperprolactinemaia is common and can seriously affect a patient’s medication adherence and long-term treatment outcome. Available data is insufficient to guide monitoring and treatment of proactine elevation in patients taking antipsychotic drugs. Previous studies either had small sample sizes or derived conclusions from pooling small studies in meta-analyses. Methods: This retrospective cohort study is based on data from the inpatient electronic medical record system of a large Chinese mental health center. Data from 10,363 inpatients (62,428 prolactin tests) with schizophrenia receiving second-generation antipsychotics (SGA) were retrieved. 6,489 cases met the inclusion crieteria for subsequent data analysis. Stratified Cox proportional hazard regression was used to compare the hazard ratios of prolactin (PRL) elevation associated with 9 SGAs. Factors that may affect PRL elevation were analyzed.Findings: In the overall population, the average PRL concentration was 57·4±58·9 ng/ml, of which 38·05±32·53 ng/ml for men and 76·10±71·24 ng/ml for women. The overall prevelance rate of abnormal PRL was 58·1%, of which 49·19% were in male and 66·67% were in female respectively. The statistical discrepancy was significant (p<0.001) in the distribution of Hyperprolactinemia (HPRL) severity between male and female individuals. PRL concentrations between men and women at different age groups were differenct as well. The risk analysis of 9 second-generation antipsychotics versus abnormal PRL concentration (>50 ng/ml) showed that antipsychotics-induced PRL abnormal (HR>1) were: Amisulpride ( hazard ratio 2·02, 95% confidence interval 1·6 to 2·63), risperidone (1·91, 1·65 to 2·23) and paliperidone (1·47, 1·11 to 1·95). Among them, amisulpride was with the highest risk. Those that did not cause PRL abmoral (HR<1) were: olanzapine (0·79, 0·67 to 0·93), quetiapine (0·75, 0·63 to 0·89), clozapine (0·61, 0·49 to 0·78), aripiprazole (0·36, 0·29 to 0·44). Among them, aripiprazole was the most effective. There were antipsychotics that were not significantly correlated with abnormal PRL elevation: ziprosidone (1·12, 0·88 to 1·44), piperopilone (0·60, 0·17 to 2·13). Amisulpride (2·46, 1·75 to 3·47) was a relatively highest risk antipsychotic among male patients while risperidone (2·05, 1·68 to 2·50) was a relatively highest risk one among female patients.Interpretation: SGAs are significantly different in inducing HPRL. Amisulpride, risperidone and paliperidone have a higher risk of PRL elevation in patients with schizophrenia while aripiprazole has a strong protective effect. Olanzapine, quetiapine and clozapine on the other hand do not have the risk of PRL elevation on average. Male and female patients are clearly different in the prevalence and its severity of HPRL in different age groups. It is necessary to analyze comprehensively in terms of gender and age in schizophrenia being treated with second-generation antipsychotics.Clinical Trial Registration Details: Registered at clinicaltrials.gov (NCT04002258).Funding Information: National Major Science and Technology Projects of China, National Shanghai Science and Technology Major Project.Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: The research project was approved by the Ethics Committee of Shanghai Mental Health Center (2019-16R).